Actavis to Buy Allergan for $66 Billion

Actavis agreed to pay $66 billion in cash and stock for Allergan in a deal that appears to have thwarted a hostile takeover of the Botox maker by Valeant and Bill Ackman.



from WSJ.com: US Business http://ift.tt/1H9qHYA

via IFTTT